News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Jeong Tae Heum
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/04/2021 |
4
| Jeong Tae Heum (Chief Finance Officer) has filed a Form 4 on Clene Inc.|
Txns:
| Granted 62,500 options to buy
@ $4.74, valued at
$296.3k
|
|
| 04/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Jeong Tae Heum (Chief Finance Officer) has filed a Form 4 on Clene Inc.|
Txns:
| Granted 130,000 options to buy
@ $6.55, valued at
$851.5k
|
|
| 01/04/2021 |
3
| Jeong Tae Heum (Chief Finance Officer) has filed a Form 3 on Clene Inc. |
| 01/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/01/2016 |
4
| Jeong Tae Heum (CFO) has filed a Form 4 on REXAHN PHARMACEUTICALS, INC.|
Txns:
| Granted 98,853 options to buy
@ $0.35, valued at
$34.6k
Granted 100,000 options to buy
@ $0.35, valued at
$35k
|
|
| 01/27/2015 |
4
| Jeong Tae Heum (CFO) has filed a Form 4 on REXAHN PHARMACEUTICALS, INC.|
Txns:
| Granted 333,332 options to buy
@ $0.71, valued at
$236.7k
|
|
| 01/12/2015 |
4
| Jeong Tae Heum (CFO) has filed a Form 4 on REXAHN PHARMACEUTICALS, INC.|
Txns:
| Sold 78,782 shares
@ $0.9004, valued at
$70.9k
Sold 188,690 shares
@ $0.9153, valued at
$172.7k
Sold 49,800 shares
@ $0.9135, valued at
$45.5k
Exercised 78,782 options to buy
@ $0.8, valued at
$63k
Exercised 188,690 options to buy
@ $0.8, valued at
$151k
Exercised 49,800 options to buy
@ $0.8, valued at
$39.8k
|
|
| 01/14/2014 |
4
| Jeong Tae Heum (CFO) has filed a Form 4 on REXAHN PHARMACEUTICALS, INC.|
Txns:
| Granted 175,000 options to buy
@ $1.14, valued at
$199.5k
|
|
| 09/11/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/05/2013 |
4
| Jeong Tae Heum (CFO) has filed a Form 4 on REXAHN PHARMACEUTICALS, INC.|
Txns:
| Granted 250,000 options to buy
@ $0.31, valued at
$77.5k
|
|
|
|